Methods for using artificial polynucleotides and compositions thereof to reduce transgene silencing
CA 2851035 C · Owner: Monsanto Technology Llc · Inventors: Flasinski, Stanislaw
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A plant cell comprising at least two polynucleotides wherein said two polynucleotides encode a substantially identical protein and at least one of the polynucleotides is a transgene and said polynucleotides are less than 85 percent identical in polynucleotide sequence for their entire length and have no polynucleotide sequence lengths more than 23 nucleotides that have 100 percent identity.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 10, 2003 and granted May 29, 2018. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 10, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 10, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.